中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2013年
14期
15-17
,共3页
何黎明%刘保国%张国忠%肖罡%姚晨
何黎明%劉保國%張國忠%肖罡%姚晨
하려명%류보국%장국충%초강%요신
椎动脉狭窄%椎动脉开口%卒中%支架置入
椎動脈狹窄%椎動脈開口%卒中%支架置入
추동맥협착%추동맥개구%졸중%지가치입
Vertebral artery stenosis%Vertebral artery ostium%Stroke%Stent placement
目的探讨支架置入治疗症状性椎动脉开口狭窄的临床疗效。方法回顾性分析支架置入治疗椎动脉开口狭窄26例患者,通过血管造影术,观察椎动脉狭窄对患者脑血流的客观影响,对椎动脉狭窄>50%的症状性患者进行血管内介入治疗。结果手术全部成功,26例患者在支架放置术中均没有发生斑块脱落而造成脑栓塞,随访6~38个月,平均(18.0±4.3)个月,随访期间经DSA或CTA复查,21例椎动脉形态良好,1例失访,3例出现轻中度再狭窄,1例重度狭窄。结论支架置入技术上是安全的,疗效满意,术后综合治疗降低了患者再次发生症状性缺血事件的风险,脑缺血症状的改善非常明显。
目的探討支架置入治療癥狀性椎動脈開口狹窄的臨床療效。方法迴顧性分析支架置入治療椎動脈開口狹窄26例患者,通過血管造影術,觀察椎動脈狹窄對患者腦血流的客觀影響,對椎動脈狹窄>50%的癥狀性患者進行血管內介入治療。結果手術全部成功,26例患者在支架放置術中均沒有髮生斑塊脫落而造成腦栓塞,隨訪6~38箇月,平均(18.0±4.3)箇月,隨訪期間經DSA或CTA複查,21例椎動脈形態良好,1例失訪,3例齣現輕中度再狹窄,1例重度狹窄。結論支架置入技術上是安全的,療效滿意,術後綜閤治療降低瞭患者再次髮生癥狀性缺血事件的風險,腦缺血癥狀的改善非常明顯。
목적탐토지가치입치료증상성추동맥개구협착적림상료효。방법회고성분석지가치입치료추동맥개구협착26례환자,통과혈관조영술,관찰추동맥협착대환자뇌혈류적객관영향,대추동맥협착>50%적증상성환자진행혈관내개입치료。결과수술전부성공,26례환자재지가방치술중균몰유발생반괴탈락이조성뇌전새,수방6~38개월,평균(18.0±4.3)개월,수방기간경DSA혹CTA복사,21례추동맥형태량호,1례실방,3례출현경중도재협착,1례중도협착。결론지가치입기술상시안전적,료효만의,술후종합치료강저료환자재차발생증상성결혈사건적풍험,뇌결혈증상적개선비상명현。
Objective To investigate the clinical effect of stent placement in the treatment of symptomatic vertebral artery ostium stenosis. Methods 26 cases with vertebral artery ostial stenosis done stent placement were retrospectively analyzed. The objective influence of vertebral artery stenosis on the patients were observed by angiography, and the patients whose symptomatic vertebral artery stenosis were greater than 50% were treated by endovascular intervention. Results The operations on all patients were successful, and no falling plaques and the subsequent cerebral thrombosis; the follow-up lasted for 6-38 months, and the average were (18.0±4.3) months, and during which period the review of DSA or CTA showed that the vertebral artery of 21 cases were in a good state, one case was not examined, 3 cases returned to mild and moderate stenosis, 1 case returned to severe stenosis. Conclusion Stent placement is safe technology and has satisfactory effect, and the after-operational comprehensive treatment can reduce the risk of the recurrence of symptomatic ischemic events, and the symptom of cerebral ischemia is greatly improved.